Allworth Financial’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $225K | Buy |
691
+73
| +12% | +$23.8K | ﹤0.01% | 1122 |
|
|
2025
Q1 | $150K | Buy |
618
+21
| +4% | +$5.09K | ﹤0.01% | 1048 |
|
|
2024
Q4 | $159K | Buy |
597
+38
| +7% | +$10.1K | ﹤0.01% | 1029 |
|
|
2024
Q3 | $154K | Sell |
559
-6
| -1% | -$1.65K | ﹤0.01% | 905 |
|
|
2024
Q2 | $134K | Sell |
565
-26
| -4% | -$6.18K | ﹤0.01% | 957 |
|
|
2024
Q1 | $88.3K | Buy |
591
+346
| +141% | +$51.7K | ﹤0.01% | 1065 |
|
|
2023
Q4 | $46.9K | Sell |
245
-16
| -6% | -$3.06K | ﹤0.01% | 1227 |
|
|
2023
Q3 | $46.2K | Buy |
261
+42
| +19% | +$7.44K | ﹤0.01% | 1149 |
|
|
2023
Q2 | $41.6K | Buy |
219
+36
| +20% | +$6.84K | ﹤0.01% | 1182 |
|
|
2023
Q1 | $36.7K | Buy |
183
+3
| +2% | +$601 | ﹤0.01% | 1184 |
|
|
2022
Q4 | $42.8K | Sell |
180
-6
| -3% | -$1.43K | ﹤0.01% | 1068 |
|
|
2022
Q3 | $37K | Buy |
186
+163
| +709% | +$32.4K | ﹤0.01% | 1062 |
|
|
2022
Q2 | $3K | Buy |
23
+8
| +53% | +$1.04K | ﹤0.01% | 1868 |
|
|
2022
Q1 | $2K | Sell |
15
-46
| -75% | -$6.13K | ﹤0.01% | 1769 |
|
|
2021
Q4 | $10K | Buy |
+61
| New | +$10K | ﹤0.01% | 1368 |
|